Enjaymo (Sutimlimab-jome)
- Medicine Name: Enjaymo
- Generic Name: Sutimlimab-jome
- Dosage Form & Strength: Injection: 1,100 mg/22 mL (50 mg/mL) in a single-dose vial
- Manufactured By: Bioverativ USA Inc.
Enjaymo (sutimlimab-jome) is a classical complement inhibitor used for the treatment of hemolysis in adult patients with cold agglutinin disease (CAD).
Recommended Dosage: The recommended dosage of Enjaymo for patients with cold agglutinin disease is based on body weight. For patients weighing 39 kg to not more than 75 kg, the recommended dose is 6,500 mg and for those weighing 75 kg or beyond, the recommended dose is 7,500 mg. Administer doses of Enjaymo intravenously (IV) weekly for the first 2 weeks, with administration every 2 weeks thereafter. Administer it at the recommended dosage regimen time points, or within two days of these time points.
In case of a missed dose, administer as promptly as possible; thereafter, resume dosing every 2 weeks. If the duration after the final dose exceeds 17 days, administer this medication weekly for two weeks, with administration every two weeks thereafter.
- Ensure respective patients are vaccinated against encapsulated bacteria. Use of Enjaymo 1,100 mg/22 mL (50 mg/mL) may elevate the risk of critical infections, including infections because of encapsulated bacteria such as Neisseria meningitidis (any serogroup), Haemophilus influenzae, and Streptococcus pneumoniae. Monitor individuals for early signs and symptoms of infections.
- Do not use Enjaymo in individuals with known hypersensitivity to sutimlimab-jome or any of the inactive ingredients. Evaluate patients for infusion-related reactions and interrupt if a reaction develops. Discontinue infusions of Enjaymo and institute suitable supportive measures in case signs of hypersensitivity reactions, such as respiratory compromise or cardiovascular instability, are established.
- Mechanisms of action suggest that this medicine may potentially increase the risk of developing autoimmune diseases such as systemic lupus erythematosus (SLE). The development of SLE has been related to inherited classical complement deficiency. Assess patients being treated with Enjaymo injections for signs and symptoms and manage them medically.
- If Enjaymo treatment is interrupted, precisely monitor patients for recurrent hemolysis, such as increased levels of total bilirubin or lactate dehydrogenase (LDH) accompanied by reduction in hemoglobin, or reappearance of symptoms such as palpitations, hemoglobinuria, fatigue, or dyspnea. Consider reinitiating treatment in case signs and symptoms of hemolysis develop after discontinuation.
What documents are required to import ENJAYMO to India?
ENJAYMO (sutimlimab-jome) injections can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID proof (issued by the government of India)
How does the order be confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from Doctor
- Import permit if applicable
Is ENJAYMO available in India?
ENJAYMO (sutimlimab-jome injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Enjaymo in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
ENJAYMO can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
IPN (Indian Pharma Network) can facilitate the supply of ENJAYMO (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Enjaymo 1,100 mg/22 mL (50 mg/mL) price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source the ENJAYMO (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network (IPN) is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Enjaymo®?
Sutimlimab-jome is a Generic Name for the trade name drug Enjaymo®.
What is the Manufacturer’s Name of Enjaymo®?
Enjaymo® is manufactured by Bioverativ USA Inc.
Is Enjaymo® approved by the FDA?
Yes, Enjaymo® is approved by the FDA. Date of first approval: February 4, 2022.
Where can I get Enjaymo® at the best price in India?
To get the best Enjaymo price in India, kindly connect with the Indian Pharma Network (a WHO GDP and ISO 9001:2008 certified company). For Enjaymo®, a valid medical prescription is needed from a treating physician.
What is the dosage and form of Enjaymo® supplied?
Enjaymo® is supplied as Injections: 1,100 mg/22 mL (50 mg/mL) in a single-dose vial for intravenous use.
What are the most common side effects of Enjaymo®?
The most common side effects of Enjaymo® are joint pain, dizziness, headache, nausea, runny nose, feeling tired or weak, cough, Raynaud’s phenomenon, bacterial infection, and increased blood pressure.
How much does Enjaymo® cost in India?
The cost of Enjaymo in India can vary. In order to procure this prescription medicine legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Enjaymo®?
Store vials refrigerated at 36-46°F (2-8°C) in the original carton to protect from light. It is not advisable to freeze or shake the vials. The unused portion needs to be discarded.
Is it safe to buy Enjaymo® online in India?
Yes, one can buy Enjaymo online in India at the lowest price from the Indian Pharma Network (IPN) if the medicine Enjaymo® is not (yet) registered or available in their country. We can help facilitate the supply of Enjaymo® through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.